Overview

Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets medical devices and has a broad portfolio of products that addresses challenging medical conditions and significant clinical needs. Penumbra sells its products to hospitals and clinics primarily through its direct sales organization in the United States, most of Europe, Canada and Australia, and through distributors in select international markets. The Penumbra P logo is a trademark of Penumbra, Inc.

NYSE: PEN 98.70 +0.50 +0.51%
Volume: 105,054
Pricing delayed 20 minutes February 16, 2018 04:01 PM

SEC Filings

Date Filing Type Filing Description Download
Date February 15, 2018 Filing Type Form SC 13G/A Filing Description Amended Statement of Ownership Download
Date February 14, 2018 Filing Type Form 5 Filing Description Annual Statement of Changes in Beneficial Ownership Download
Date February 14, 2018 Filing Type Form 5 Filing Description Annual Statement of Changes in Beneficial Ownership Download

IR Contact

investors@penumbrainc.com

Penumbra, Inc. Headquarters One Penumbra Place
Alameda, CA 94502
USA